Company Research Report: Reveles Inc.

Company Overview

Name: Reveles Inc.

Mission: Pioneering representation in equity-driven decentralized clinical trials. The company aims to establish deep partnerships with sponsors, CROs, and research sites, and work tirelessly to expand access and increase awareness of clinical research.

Founded By: R'Kes Starling, who was inspired by personal circumstances in the healthcare sector when he realized the need for better access to clinical trials for underserved populations.

Key People:

R'Kes Starling, Founder & Chief Executive Officer

Tendai Tawonezvi, Director of Clinical Operations

Ian Scholes, Head of Customer Success

Shamir Dayalji, CPA, Controller

Headquarters: 550 Reserve Street, Suite 190, Southlake, Texas 76092-9205

Number of Employees: No information is available

Revenue: No information is available

Known For: Leading in decentralized clinical trial solutions, emphasizing diversity and equity in healthcare, and utilizing advanced technology for patient-centered clinical trial solutions.

Products

Reveles provides a range of services aimed at enhancing decentralized clinical trial execution:

Decentralized Clinical Solutions:

Full-service execution for modern clinical trials.

Comprehensive patient education and engagement empowered by AI.

Hyper-targeted patient recruitment strategies.

Effective patient retention tactics.

Key Features:

In-Home Clinical Trial Support Services: Includes leveraging a network of nurses, project management, lab sample collection, drug administration, and adherence to trial protocols.

eConsent: Offers a digital consent solution to enhance patient understanding and retention.

Telemedicine: Facilitates remote, real-time data collection and patient-site communications through various digital means.

Direct Data Collection: Engages patients through mobile apps to reduce burden via alerts and reminders.

Blockchain-based Platform: Manages patient lifecycle in trials for increased transparency and data integrity.

Recent Developments

Recent Developments: Reveles is pioneering the use of decentralized clinical trials as an effective strategy for widening clinical trial access and success rates, particularly post-COVID-19.

New Products Launched: No specific new product launches are mentioned.

New Features: No information is available on specific updates or new features added to existing products.

New Partnerships: No information is available on new partnerships.

Strategic Approach

Reveles employs a consultative selling approach focusing on flexibility, operational excellence, and high-touch services to offer best-in-class clinical research. The company also emphasizes employee collaboration, accountability, and innovation as core values to drive their operations.